The global Stroke Diagnostic and Therapeutic Market is projected to reach US$ 65.6 billion by the end of the year 2030, and growing at a CAGR of 8% from 2021 to 2030. The latest study collated and published by Precedence Research analyzes the historical and present-day scenario of the global Stroke Diagnostic and Therapeutic market in order to accurately gauge its future growth. The study presents detailed information about the important growth factors, restraints, and trends that are creating a landscape for the growth of the global Stroke Diagnostic and Therapeutic market so as to identify growth opportunities for market stakeholders. The report also provides insightful information about how the global Stroke Diagnostic and Therapeutic market would expand during the forecast period of 2021 to 2030. Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1212 The report offers intricate dynamics about different aspects of the global Stroke Diagnostic and Therape...
The global DNA Sequencing Market is projected to reach US$ 40.64 billion by the end of the year 2030, and growing at a CAGR of 17.5% from 2021 to 2030.
The latest study collated and published by Precedence Research analyzes the historical and present-day scenario of the global DNA Sequencing market in order to accurately gauge its future growth. The study presents detailed information about the important growth factors, restraints, and trends that are creating a landscape for the growth of the global DNA Sequencing market so as to identify growth opportunities for market stakeholders. The report also provides insightful information about how the global DNA Sequencing market would expand during the forecast period of 2021 to 2030.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1189
The report offers intricate dynamics about different aspects of the global DNA Sequencing market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global DNA Sequencing market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of the global DNA Sequencing market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
This study covers a detailed segmentation of the global DNA Sequencing market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global DNA Sequencing market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Market Segmentation
By Product
- Instruments
- Consumables
- Services
By Technology
- Third Generation DNA Sequencing
- Next-Generation Sequencing
- Sanger Sequencing
By Application
- Clinical Investigation
- Oncology
- Forensics & Agrigenomics
- Reproductive Health
- HLA Typing
- Others
By End-Use
- Clinical Research
- Academic Research
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
- North America
Key Players
- Agilent Technologies
- Illumina, Inc.
- QIAGEN
- Perkin Elmer
- Thermo Fisher Scientific
- Hoffmann-La Roche Ltd.
- Macrogen, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies Ltd.
- Myriad Genetics
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1189
Research Methodology
The research methodology adopted by analysts for compiling the global DNA Sequencing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global DNA Sequencing market.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. DNA Sequencing Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on DNA Sequencing Market
5.1. Covid-19: DNA Sequencing Industry Impact
5.2. DNA Sequencing Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and DNA Sequencing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for DNA Sequencing Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. DNA Sequencing Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Technological advances in next-generation sequencing technologies
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rising demand for precision medicine
6.1.3.2. Technological advancements
Chapter 7. Global DNA Sequencing Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. DNA Sequencing Market Revenue by Market Players (2016 -2019)
7.1.1.2. DNA Sequencing Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global DNA Sequencing Market, By Product
8.1. DNA Sequencing Market, by Product, 2017 - 2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017 - 2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017 - 2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017 - 2030)
Chapter 9. Global DNA Sequencing Market, By Technology
9.1. DNA Sequencing Market, by Technology, 2017 - 2030
9.1.1. Third Generation DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2017 - 2030)
9.1.2. Next-Generation Sequencing
9.1.2.1. Market Revenue and Forecast (2017 - 2030)
9.1.3. Next-Generation Sequencing
9.1.3.1. Market Revenue and Forecast (2017 - 2030)
Chapter 10. Global DNA Sequencing Market, By Application
10.1. DNA Sequencing Market, by Application, 2017 - 2030
10.1.1. Clinical Investigation
10.1.1.1. Market Revenue and Forecast (2017 - 2030)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2017 - 2030)
10.1.3. Forensics & Agrigenomics
10.1.3.1. Market Revenue and Forecast (2017 - 2030)
10.1.4. Reproductive Health
10.1.4.1. Market Revenue and Forecast (2017 - 2030)
10.1.5. HLA Typing
10.1.5.1. Market Revenue and Forecast (2017 - 2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017 - 2030)
Chapter 11. Global DNA Sequencing Market, By End Use
11.1. DNA Sequencing Market, by End-Use, 2017 - 2030
11.1.1. Clinical Research
11.1.1.1. Market Revenue and Forecast (2017 - 2030)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2017 - 2030)
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2017 - 2030)
11.1.4. Hospitals & Clinics
11.1.4.1. Market Revenue and Forecast (2017 - 2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017 - 2030)
Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Product(2017 - 2030)
12.1.2. Market Revenue Forecast by Technology(2017 - 2030)
12.1.3. Market Revenue Forecast by Application (2017 - 2030)
12.1.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017 - 2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017 - 2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017 - 2030)
12.2.2. Market Revenue Forecast by Technology (2017 - 2030)
12.2.3. Market Revenue Forecast by Application (2017 - 2030)
12.2.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017 - 2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017 - 2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017 - 2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017 - 2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017 - 2030)
12.3.2. Market Revenue Forecast by Technology (2017 - 2030)
12.3.3. Market Revenue Forecast by Application (2017 - 2030)
12.3.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017 - 2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017 - 2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017 - 2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017 - 2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017 - 2030)
12.4.2. Market Revenue Forecast by Technology (2017 - 2030)
12.4.3. Market Revenue Forecast by Application (2017 - 2030)
12.4.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017 - 2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017 - 2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017 - 2030)
12.5.2. Market Revenue Forecast by Technology (2017 - 2030)
12.5.3. Market Revenue Forecast by Application (2017 - 2030)
12.5.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017 - 2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017 - 2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017 - 2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017 - 2030)
Chapter 13. Company Profiles
13.1. Agilent Technologies
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.1.4. Recent Developments and Strategies
13.2. Illumina, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.2.4. Recent Developments and Strategies
13.3. QIAGEN
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.3.4. Recent Developments and Strategies
13.4. Perkin Elmer
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.4.4. Recent Developments and Strategies
13.5. Thermo Fisher Scientific
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.5.4. Recent Developments and Strategies
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.6.4. Recent Developments and Strategies
13.7. Macrogen, Inc.
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.7.4. Recent Developments and Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.8.4. Recent Developments and Strategies
13.9. Oxford Nanopore Technologies Ltd.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.9.4. Recent Developments and Strategies
13.10. Myriad Genetics
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.10.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Complete Payment Process and Get Full Access of this Research Report@ https://www.precedenceresearch.com/checkout/1189
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Comments
Post a Comment